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A B S T R A C T
Four immunocompetent adults presented with
protracted fever lasting > 6 weeks and severe
weight loss, associated with primary cytomegalo-
virus (CMV) infection. Each patient had spleen
enlargement, lymphocytosis and hypertriglyce-
ridaemia, but recovered spontaneously. A further
20 immunocompetent patients with primary
CMV infection were also reviewed, and all
presented the usual clinical picture of CMV
mononucleosis. It was concluded that CMV
mononucleosis should be considered in the
differential diagnosis in patients with prolonged
fever and weight loss if lymphocytosis is present.
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Symptomatic primary cytomegalovirus (CMV)
infection in immunocompetent adults usually
presents as a mild self-limited mononucleosis
[1]. In some cases, fever is prolonged and may be
considered in the differential diagnosis of fever of
unknown origin [2]. However, to our knowledge,
CMV infection has not been described as a cause
of prominent weight loss in immunocompetent
adults. In this study, the medical charts of all
immunocompetent adults diagnosed with pri-
mary CMV infection in our unit in the period
1997–2002 were reviewed. Patients were consid-
ered to have CMV mononucleosis if they presen-
ted with a fever plus absolute (> 5 · 109 ⁄mm3) or
relative (> 50%) lymphocytosis with atypical
lymphocytes, and (a) isolation of CMV from
blood or (b) isolation of CMV from urine, plus
one of the following: CMV-IgM seroconversion
[3]; or positive CMV-IgM in two serum samples
taken 2 weeks apart with a four-fold increment in
CMV-IgG titres [4]. Other causes of mononucle-
osis (e.g., Epstein–Barr virus (EBV), Toxoplasma,
HIV infection, and others if clinically indicated)
were always excluded [5]. Exclusion criteria were:
age of < 14 years, HIV infection, renal failure,
cirrhosis, neoplasia, transplantation, use of ster-
oids or other immunosuppressive drugs, and
blood product transfusion or heart surgery in
the previous 6 months. In total, 24 patients were
diagnosed with CMV mononucleosis. Among
these, four patients presented with a more
protracted clinical course, including fever lasting
‡ 6 weeks, and body weight loss of ‡ 10%. The
laboratory data for these four patients (group 1)
are shown in Table 1. The remaining patients
with spontaneous primary CMV infection were
analysed as the reference group (group 2). No
statistical comparisons were performed, as only
four patients were included in group 1. Detection
of CMV in cell culture was performed by spin
amplification shell vial assay [6]. Anti-CMV IgM
and IgG antibodies were determined in serum
using the enzyme-linked fluorescent assay (Vidas;
bioMe´rieux, Hazelwood, MO, USA).
The clinical presentations of the four patients in
group 1 were as follows.
1. A male aged 66 years with arterial hyperten-
sion was admitted with a 4-week history of
malaise, fatigue, fever (38.8 C), night sweats
and weight loss (25 kg). He looked moderately
ill. Ultrasonography disclosed hepatospleno-
megaly. Blood and urine cultures for bacteria,
purified protein derivative tests for tuberculo-
sis, and serological tests for Brucella, Treponema
pallidum, Coxiella burnetti, Chlamydia, Toxoplasma,
EBV and HIV were all negative. CMV-IgM was
positive in two serial serum samples, and CMV
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was isolated from blood. The fever subsided
spontaneously after 5 weeks and the patient
started to recover weight. The patient was
asymptomatic 2 years later.
2. A male aged 32 years presented with a 3-week
history of fever, fatigue, scanty cough and
weight loss (13 kg). Physical examination was
normal except for splenomegaly. Blood cul-
tures and serological tests for Brucella,
C. burnetti, EBV, Toxoplasma and HIV were
negative. CMV-IgM was negative in the first
serum sample, but positive after a further
2 weeks, and CMV was isolated from urine.
The fever resolved spontaneously after
7 weeks. The patient regained his previous
weight 7 weeks after the fever subsided.
3. A male aged 35 years was admitted because of
fever, headache, fatigue, weight loss (8 kg),
cough and thoracic pain which had begun
1 month earlier. Physical examination dis-
closed hepatosplenomegaly. A chest X-ray
disclosed a bilateral interstitial infiltrate. Spu-
tum and blood cultures, purified protein deriv-
ative test and serology for C. burnetti,
Chlamydia, Mycoplasma pneumoniae, influenza
viruses, Legionella, EBV, HIV, Toxoplasma,
hepatitis viruses A, B and C, and Brucella,
were all negative. CMV-IgM was negative in
the first serum sample, but positive after a
further 2 weeks. CMV was isolated from urine
(blood culture was not done). Fever and the
other symptoms subsided spontaneously after
4 weeks, but the previous weight was only
regained after a further 10 weeks.
4. A male aged 32 years presented with a 3-week
history of fever, fatigue and malaise, with a
10-kg loss of body weight. Splenomegaly was
felt. The rest of the physical examination was
unremarkable and chest X-ray was normal.
Blood cultures and serological studies, inclu-
ding C. burnetti, T. pallidum, HIV, EBV and
Toxoplasma, were negative. The first serum
sample was negative for CMV-IgM, but a
second sample was positive. CMV was isolated
from urine and blood. The patient recovered
uneventfully after 8 weeks without treatment,
and the previous weight was recovered
3 weeks after the disappearance of the fever.
The other 20 patients (group 2) were diagnosed
with CMV mononucleosis. Their data are shown
in Table 2 in comparison with those of group 1.
Several complications or associated manifesta-
tions have been described in immunocompetent
patients with CMV infection, including severe
pneumonia, granulomatous hepatitis [7], Guil-
lain–Barre´ syndrome [8], meningoencephalitis [9],
myocarditis [10], thrombocytopenic purpura
[11], erythema nodosum [12], crioglobulinaemia
[13], vasculitis [14], vascular thrombosis [15] and
colitis [16]. Protracted CMV infections with mal-
aise, fever and persistent lymphocytosis have
been described in infants [17], but we are not
aware of reported cases of CMV mononucleosis as
a cause of protracted fever with prominent weight
loss in immunocompetent adults.
Table 1. Laboratory data on admis-
sion for patients in group 1
Normal values Case 1 Case 2 Case 3 Case 4
WBC · 1000 ⁄ lL 4.0–11.0 9.6 11.7 12.8 19.8
Lymphocytes (%) 16–45 55 54 70 86
Haemoglobin (g ⁄dL) 12.0–17.5 10.8 11.3 14.0 14.1
ESR (mm ⁄h) < 15 87 56 15 10
AST (U ⁄L) < 37 74 54 176 60
ALT (U ⁄L) < 40 77 81 396 60
Alkaline phosphatase (U ⁄L) 90–258 102 49 105 72
Total bilirubin (mg ⁄dL) < 1.0 0.7 0.6 0.7 1.0
Triglycerides (mg ⁄dL) 70–170 286 229 258 280
WBC, white blood cell; ESR, erythrocyte sedimentation rate; AST, aspartate aminotransferase; ALT, alanine
aminotransferase.
Table 2. Demographic, clinical and laboratory features of
patients
Group 1 (n ¼ 4) Group 2 (n ¼ 20)
Mean age in years (range) 41.2 (32–66) 26.3 (13–44)
Male gender (%) 100 65
Duration of fever (days) 69.2 (± 15.9) 29.7 (± 5)
Lymphadenopathies (%) 0 45
Hepatomegaly (%) 50 30
Splenomegaly (%) 100 35
Abdominal pain (%) 0 15
Cough (%) 25 25
WBC · 1000 ⁄ lL 13.4 (± 2.2) 10.8 (± 1.0)
Percentage of lymphocytes 66 (± 7) 58 (± 2)
ESR (mm ⁄h) 37 (± 17) 25 (± 4)
ALT (U ⁄L) 91 (± 28) 161 (± 40)
AST (U ⁄L) 156 (± 80) 291 (± 619)
Triglycerides (mg ⁄dL) 263 (± 12) 192 (± 25)
Data are expressed as mean values except where indicated. Abbreviations as in
Table 1.
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In this study, the clinical manifestations and
laboratory data for patients in group 2 were
similar to those described previously for CMV
mononucleosis in healthy adults [1,4,5], but four
patients presented with a more protracted clinical
course in which fever and significant weight loss
were the prominent symptoms. All of these
patients had splenomegaly, but none had periph-
eral lymphadenopathies. The main diagnostic
considerations were lymphoma, other occult neo-
plasia, systemic vasculitis, or a chronic infection.
The clue for diagnosis was the presence of
lymphocytosis with activated lymphocytes.
The four patients had hypertriglyceridaemia.
The cytokines that mediate the immune response
to infection are known to induce changes in lipid
metabolism, particularly hypertriglyceridaemia
[18]. With the available data, it can be speculated
that weight loss in these immunocompetent
patients was cytokine-mediated. In summary,
CMV infection should be considered in previ-
ously healthy patients with protracted fever and
weight loss when lymphocytosis is present. In
such patients, CMV serology and blood culture
should be performed if possible, bearing in mind
that, in some cases, it may take 4–6 weeks before
specific antigens can be detected. In the case of
positive results, other expensive or aggressive
diagnostic tests that are usually performed in
cases of fever of unknown origin can be avoided.
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